Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

15 Jul 2011 07:00

RNS Number : 4487K
Alumasc Group PLC
15 July 2011
 



 

For release 7am, 15 July 2011

 

THE ALUMASC GROUP PLC - TRADING UPDATE

 

The Alumasc Group plc (ALU:L), the premium building and engineering products company, is providing a trading update relating to the year ended 30 June 2011.

 

Group revenues are expected to be in line with previous expectations. However, margins in the Building Products division for the fourth quarter were significantly lower than expected as a result of rising input costs that could not be recovered fully from customers, against a background of continued weakness in the UK construction market. In particular, the group's Construction Products business experienced a 20% increase in steel costs towards the end of the financial year, with profitability further diluted by an increase in the proportion of lower margin export sales. Consequently, underlying group profit for the full year is expected to be ahead of last year, but below previous management expectations.

 

Net cash flow performance to the year end continued to be robust and remained ahead of expectations.

 

Alumasc Precision recovered strongly during the year, benefiting from international demand for aluminium components used mainly in off-highway diesel engines, and particularly those used in mining and construction vehicles being sold into emerging economies. In view of the strong resurgence at Alumasc Precision over the last eighteen months and the encouraging future prospects for this business, the impairment charge booked in 2009 is to be reversed. This will give a one-off, non-cash gain of £1.2 million in the financial year just ended. As a consequence, the group's statutory profit before tax is expected to exceed underlying profit, and be well ahead of the prior year statutory result.

 

This impairment charge reversal will increase the book value of plant and equipment and therefore give rise to a higher depreciation charge of £0.3 million per annum in the 2011/12 financial year and beyond.

 

There is early evidence that a greater number of large buildings are now beginning to be funded, which could benefit Levolux, in particular, in the group's 2012/13 financial year. This is broadly consistent with external construction industry forecasts as to the expected timing of a return to growth. In the meantime, export sales strategies are beginning to add incrementally to Alumasc's revenues, and there are numerous initiatives across the group to mitigate the impact of the specific current weakness in the UK commercial new build sector, diversify routes to market and introduce new and innovative products.

 

Alumasc Precision continues to grow, although it is anticipated that growth will be at a more sustainable rate whilst the business prepares for the next phase of the project won last October to supply components for larger engine transmission systems, expected to start late in 2012.

 

In view of the continued strong group order book at Alumasc Precision, and the factors outlined above, the Board expects Alumasc to continue to make steady progress in 2011/12.

 

The Board will review the group dividend ahead of the announcement of its full year results in September in the light of current trading and future prospects at that time.

 

The results for the year ended 30 June 2011 will be announced on Tuesday, 6th September 2011. A presentation to analysts will be made at 9.30am on that day, at the offices of Peel Hunt, 111 Old Broad Street, London EC2N 1PH.

 

Enquiries:

 

The Alumasc Group plc

Paul Hooper (Group Chief Executive) Tel: 01536 383821

Andrew Magson (Group Finance Director) Tel: 01536 383844

 

Bankside Consultants

Simon Bloomfield or James Irvine-Fortescue Tel: 0207 367 8861

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFADAISLIL
Date   Source Headline
15th Dec 20233:30 pmRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSCMA clearance on proposed acquisition of ARP Group
30th Oct 20239:00 amRNSAcquisition of ARP Group - Update on CMA process
26th Oct 202312:34 pmRNSResult of AGM
26th Oct 20237:00 amRNSAGM Trading Update
22nd Sep 202312:14 pmRNSNotice of AGM
5th Sep 20237:00 amRNSFinal Results
8th Aug 202310:54 amRNSNotice of Results
2nd Aug 20239:30 amRNSDirector/PDMR Shareholding
27th Jul 20231:54 pmRNSDirector/PDMR Shareholding
26th Jul 202310:00 amRNSDirector/PDMR Shareholding
25th Jul 20237:00 amRNSAcquisition of ARP Group
20th Jul 20237:00 amRNSFull Year Trading Update
7th Feb 20237:00 amRNSInterim Results
24th Jan 20237:00 amRNSNotice of Investor Presentation
11th Jan 20237:02 amRNSNotice of Results
30th Nov 20227:00 amRNSInternational Contract Wins
1st Nov 20229:00 amRNSDirector/PDMR Shareholding
1st Nov 20228:45 amRNSDirector/PDMR Shareholding
27th Oct 202211:28 amRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement
21st Sep 20223:20 pmRNSNotice of AGM
6th Sep 20227:00 amRNSFull Year Results
2nd Sep 20222:04 pmRNSNotice of Investor Presentation
26th Aug 20227:00 amRNSSale of Levolux
16th Aug 20229:57 amRNSNotice of Results
28th Apr 20227:00 amRNSChange of Auditor
10th Feb 20227:00 amRNSDirector/PDMR Shareholding
9th Feb 20229:42 amRNSDirector/PDMR Shareholding
8th Feb 20227:00 amRNSInterim results
11th Jan 202211:30 amRNSHolding(s) in Company
10th Jan 202210:00 amRNSNotice of Interim Results
6th Dec 202112:00 pmRNSDirector/PDMR Shareholding
6th Dec 20217:00 amRNSAppointment of a NED and Committee Chair
2nd Dec 20213:21 pmRNSDirector/PDMR Shareholding
29th Nov 202112:30 pmRNSDirector/PDMR Shareholding
26th Nov 20217:00 amRNSChairman succession
17th Nov 20217:00 amRNSAlumasc receives Green Economy Mark
29th Oct 202110:12 amRNSDirector/PDMR Shareholding
22nd Oct 20211:09 pmRNSGroup Company Secretary and PDMR
21st Oct 20212:19 pmRNSDirectorate Change and Results of AGM
21st Oct 20217:00 amRNSAGM Trading Update
19th Oct 20213:03 pmRNSDirector/PDMR Shareholding
12th Oct 20213:15 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSExport Contract Wins
21st Sep 20212:35 pmRNSNotice of AGM
7th Sep 20217:00 amRNSFULL YEAR RESULTS ANNOUNCEMENT
19th Aug 202111:56 amRNSNotice of Results
15th Jul 20217:00 amRNSTrading Update
16th Jun 202112:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.